As an example, MMP-9 is elevated in breast cancer patients, including tumor cells; additionally, serum, plasma, and urine may be also useful for early cancer diagnosis and metastasis prediction, and MMP-13 correlates with aggressiveness of the tumor and poor prognosis in HER2-positive tumors. Here, ERBB2 is linked to neoplasm.